Medications for STEMI and NSTEMI Most pharmacological evidence to support choice of treatment is based on trials from patients with STEMI, so applying this evidence to NSTEMI patients, although often done, requires some caution.

2023年10月5日 · Treatments differ for a STEMI versus NSTEMI heart attack, although there can be some overlap. Hospitals use techniques to restore blood flow to the part of the heart muscle damaged during your heart attack: You might receive clot-dissolving drugs (thrombolysis), balloon angioplasty, surgery or a combination of treatments.

Patients with severe and acute myocardial infarction (ie, ST-elevation myocardial infarction [STEMI]) require rapid diagnosis and treatment to reduce the risk of death and permanent myocardial injury .

2004年8月3日 · RALES (Randomized Aldactone Evaluation Study) and EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) support the long-term use of an aldosterone blocker in STEMI patients with heart failure, an ejection fraction of 0.40 or less, or both, provided the serum creatinine is less than or equal to 2.5 mg ...

2018年1月25日 · Treatment of acute coronary syndromes (ACS) is designed to relieve distress, interrupt thrombosis, reverse ischemia, limit infarct size, reduce cardiac workload, and prevent and treat complications. An ACS is a medical emergency; outcome is greatly influenced by rapid diagnosis and treatment. Treatment occurs simultaneously with diagnosis.

Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.

2017年2月15日 · Table 1 summarizes the medications used to manage ACS. 4, 5 Dual antiplatelet therapy is highly recommended in the treatment of STEMI to support primary PCI and fibrinolytic treatment...

2021年6月2日 · A review of four international guidelines on pharmacotherapy for ST-elevation myocardial infarction, from symptom onset to secondary prevention treatment.

Initial medical management of STEMI consists of relief of ischemic pain with nitrates and morphine, antithrombotic measures including antiplatelet agents (aspirin, thienopyridines and...

2009年6月15日 · Oral clopidogrel (Plavix) at a dosage of 75 mg daily should be added to aspirin therapy in patients with STEMI, whether or not they undergo reperfusion therapy. Oral beta...